Position in AXSM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$236,734,690
+$40,167,642 QoQ
Shares Held
967,172
-16.8% QoQ
Ownership
1.85%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 503 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. AXSM ranks #19 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in AXSM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $236,734,690 | 967,172 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $196,567,048 | 1,162,981 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $184,511,877 | 1,010,249 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $121,170,664 | 997,700 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $103,288,998 | 989,453 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $109,031,905 | 934,853 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $77,209,839 | 912,538 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $81,643,209 | 908,459 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $71,234,047 | 884,895 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $67,463,478 | 845,407 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $65,447,175 | 822,304 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $54,409,015 | 778,495 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $51,003,928 | 709,768 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $40,242,252 | 652,436 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $48,174,549 | 624,589 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $25,102,721 | 562,589 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $20,366,101 | 531,752 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $22,186,033 | 536,024 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $19,172,783 | 507,485 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $16,197,532 | 491,430 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $32,600,045 | 483,250 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $26,531,395 | 468,587 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $34,812,212 | 427,301 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $29,750,865 | 417,556 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $35,042,146 | 425,889 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $24,193,837 | 411,250 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||